ESC 2018: Rivaroxaban Not Effective for Heart Failure With Sinus Rhythm and Coronary Disease
Thrombin-related events are likely not the major driver of cardiovascular events in recent worsening of chronic heart failure.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.